Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01378195 · ClinicalTrials.gov registry record · Phase 2
iCare Stress Management e-Training for Dementia Family Caregivers
A Phase 2 study of Dementia and Alzheimers Disease, sponsored by Photozig.
- Completed
- Registry status
- Phase 2
- Development phase
- 150
- Enrollment target
- 1
- Study location
NCT01378195 is a Phase 2 study of Dementia and Alzheimers Disease that has completed, run by Photozig. The registered enrollment target is 150 participants, below the 7,722-participant average among 199 other Dementia trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01378195, a Phase 2 study of Dementia and Alzheimers Disease, has completed, sponsored by Photozig.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
Photozig and Stanford University are creating a program to help cope with caregiving, alleviate related stress, and enhance quality of life for caregivers, with funding from the National Institute on Aging. This home-based program includes a free DVD, printed materials, and resource website. In addition, after completing the program, participants will have free access to final online resources for 1 year. There are no face-to-face meetings, and participants can live anywhere in the United States.
Conditions Studied
Interventions
- BEHAVIORAL CBT-based program for dementia caregivers
- BEHAVIORAL Educational/Resources program
Study Locations (1)
California
- Photozig, Inc. - Moffett Field
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2011-05 |
| Est. Completion | 2012-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01378195
The ClinicalTrials.gov registry entry for NCT01378195 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 7,722-participant average among 199 other Dementia trials with a reported enrollment target (98% lower). The listed sponsor is Photozig, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Dementia appearing as the primary indexed condition, and to 2 interventions - of which CBT-based program for dementia caregivers is the first listed.
NCT01378195 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT01378195 about?
NCT01378195 is a clinical study titled "iCare Stress Management e-Training for Dementia Family Caregivers". Photozig and Stanford University are creating a program to help cope with caregiving, alleviate related stress, and enhance quality of life for caregivers, with funding from the National Institute on Aging. This home-based program includes a free DVD, printed materials, and resource website. In addi...
What is the current status of trial NCT01378195?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 150 participants. The study started on 2011-05. Estimated completion is 2012-07.
What conditions does trial NCT01378195 study?
This clinical trial studies the following conditions: Dementia, Alzheimers Disease.
What interventions are being tested in trial NCT01378195?
The interventions under investigation include: CBT-based program for dementia caregivers (BEHAVIORAL), Educational/Resources program (BEHAVIORAL).
Who is sponsoring clinical trial NCT01378195?
This trial is sponsored by Photozig, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01378195 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dementia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Clinical Trial Evaluating the Efficacy of AGB101 for Reducing Hippocampal Overactivity in Older Adults
RECRUITING · Phase 2
-
Assessment of Foralumab Safety and Modulation of Microglial Activation in Alzheimer's Disease
RECRUITING · Phase 2
-
A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
RECRUITING · Phase 2
-
A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
RECRUITING · Phase 2
-
Testing the Pain Clinical Practice Guideline
RECRUITING · Phase 2
-
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation (DIAN-TU)
ACTIVE NOT RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.